CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $16,241,000 | -0.4% | 4,587,716 | +13.7% | 0.00% | 0.0% |
| Q3 2016 | $16,302,000 | -1.4% | 4,035,089 | +7.1% | 0.00% | -25.0% |
| Q2 2016 | $16,539,000 | +21.5% | 3,767,356 | +4.6% | 0.00% | +33.3% |
| Q1 2016 | $13,609,000 | -75.8% | 3,600,323 | +0.4% | 0.00% | -76.9% |
| Q4 2015 | $56,221,000 | +41.8% | 3,585,519 | -4.7% | 0.01% | +30.0% |
| Q3 2015 | $39,651,000 | -56.8% | 3,761,916 | +3.4% | 0.01% | -54.5% |
| Q2 2015 | $91,796,000 | -11.4% | 3,639,813 | -2.1% | 0.02% | -12.0% |
| Q1 2015 | $103,645,000 | +69.9% | 3,718,889 | +11.3% | 0.02% | +66.7% |
| Q4 2014 | $60,986,000 | +55.1% | 3,341,726 | +10.1% | 0.02% | +36.4% |
| Q3 2014 | $39,324,000 | -21.2% | 3,034,230 | -0.8% | 0.01% | -21.4% |
| Q2 2014 | $49,902,000 | -15.7% | 3,057,751 | -8.7% | 0.01% | -22.2% |
| Q1 2014 | $59,195,000 | -22.4% | 3,350,054 | +6.4% | 0.02% | -21.7% |
| Q4 2013 | $76,235,000 | -27.9% | 3,148,910 | +5.5% | 0.02% | -36.1% |
| Q3 2013 | $105,790,000 | +160.5% | 2,985,877 | +14.8% | 0.04% | +140.0% |
| Q2 2013 | $40,616,000 | – | 2,601,925 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |